VISFO has successfully started its scholarship programme at the University of York. The aim of the programme is to give students from a widening partcipatory background better access to higher education, with an opportunity to take part in a groundbreaking project that will encourage the students to come together to create a ‘social good’.

The scholarships will provide financial funding to help students to get the most out of their studies and enrichment activities, without the added stress of money worries.

As part of the programme, scholars will be able to collaborate on Hypergrad – a long-term charity group project, developed to promote social good. The Hypergrad concept aims to help students to enhance their employability, develop a personal brand, improve their overall wellness and boost their career outlook after graduation.

Dr Max Noble, founder and CEO of VISFO, said: “It’s really exciting to be able to kick-start the Enigma programme with the University of York. As a York alumnus I am hugely proud be able to give back to the institution that supported me and create something that will hopefully make a huge difference to each student.”

Noble officially introduced the Enigma scholarships at the University of York, where he met the students enrolled in the fully funded three-year programme.
  
He added: “At VISFO we have experts from across the pharmaceutical industry with years of experience under their belts. Through this completely unique scholarship I’m hoping to offer the students not only funding, but access to advice and support from established professionals that will fast-track their careers to the next level.”

Noble gave an informal presentation at the scholarship launch, where he was joined by members of the VISFO team. Attendees were introduced to industry experts across the pharmaceutical space in fields including software, medicine and marketing, who will be accessible throughout the scholarship to provide regular mentoring and advice.

Tracy Lightfoot, the pro-vice chancellor for teaching, learning and students at the University of York said: “This scholarship presents a new way of working for us, and one that will not only provide financial benefit to students, but an inspirational programme of mentorship, cohort building and engagement with enterprise.”

The new branding combines Nucleus Global medical communications, consulting, continuing medical education and creative digital agencies – Articulate Science, Cognito Medical, Chrysalis, Health Interactions, IMNE, Integress, Clinical Thinking, International Medical Press, Medical Expressions, Meditech Media, Nucleus X Consulting, Scientific Pathways, Scimentum and Synaptik Digital.

Speaking on the development at the company, Daniel Bridges, CEO, said: “It is an incredibly exciting time at Nucleus Global and we wanted to update our look to better reflect the work of our fantastic teams that help us remain at the forefront of the medical communications industry while still maintaining our heritage ethos of being an entrepreneurial but collaborative family of companies.”

Jim Lothrop, vice president, creative and digital at Synaptik Digital, said: “We did this together, as one team working toward a common goal to represent the whole of Nucleus Global as the amazing family of agencies it truly is. Every team member touching this project helped bring our brand vision to life. Under this new branding, we are one unified group focused on creating the best medical communications, creative and content engagement for the healthcare industry.”